PROMIS Fatigue short forms are reliable and valid in adults with rheumatoid arthritis.
Clifton O Bingham Iii, Anna Kristina Gutierrez, Alessandra Butanis...
https://pubmed.ncbi.nlm.nih.gov/30790155/Actively Recruiting
Led by Motiva USA LLC · Updated on 2026-07-17
2400
Participants Needed
33
Research Sites
17 weeks
Total Duration
This research aims to evaluate the use and safety of Motiva Implants in people undergoing breast implant procedures. The study focuses on collecting and assessing safety and effectiveness data about these implants after they have been approved and are in general use. It includes participants who have primary breast augmentation, revision breast augmentation, or other aesthetic surgeries, with a focus on female patients aged 22 and older. Participants will receive Motiva Implants as part of their breast surgery or undergo other aesthetic procedures. The study is prospective and non-randomized, with data collected at baseline before surgery, during the operation, and annually for up to 10 years after surgery. Participants who have revision surgery or other aesthetic procedures without implants are also included as control groups to compare outcomes. During the study, participants will have various assessments including medical imaging such as CT, ultrasound, or MRI if medically advised. Researchers will monitor for connective tissue disease signs and symptoms, reproductive complications, cancer diagnoses, local complications, and patient satisfaction over 10 years. The impact of RFID on imaging will also be assessed. Participants will be followed for up to 10 years, providing long-term data on the safety and performance of Motiva Implants.
CONDITIONS
Motiva Implants® Post-Approval Study
M
Motiva USA LLC
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Motiva USA LLC
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Motiva Implants (silicone gel‑filled) | Control: Other aesthetic surgery | External Context: Fat transfer augmentation |
|---|---|---|---|
| What the option is | A silicone gel‑filled breast implant device under study for primary and revision augmentation | Non‑implant aesthetic surgical procedures such as liposuction or facelift used as the control group | Fat transfer uses the patient’s own fat for implant‑free breast augmentation |
| Role in the trial | Investigational device arm under evaluation | Control group receiving other aesthetic surgery procedures | Implant‑free standard surgical alternative outside this trial |
| Primary use | Breast augmentation in primary or revision surgery | Undergoing other types of aesthetic surgery not involving breast implants | Augmentation using autologous fat for those avoiding implants |
| How it is performed | Surgical placement of silicone gel‑filled implant | Surgical aesthetic procedures such as liposuction or rhinoplasty | Autologous fat harvested and injected into the breast tissue |
| Evidence status | Clinical evidence being collected over 10 years to track long‑term outcomes | Standard cosmetic approaches with broadly established outcomes outside study | Peer‑reviewed long‑term series show high satisfaction and durable volume retention |
| Important risks | Not yet established; safety monitoring ongoing in this post‑approval study | General surgical risks depend on procedure type; not specified in trial | Low reported complications in long‑term series; procedural risks likely similar to implant‑free surgery |
| Important limitations | Long duration (10 years) means final safety outcomes are pending | Control group differs in procedure intent and may limit direct comparability for breast implant outcomes | External evidence from a non‑randomized, single‑surgeon series may not generalize to all settings |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 10 years
Participants undergo primary or revision breast augmentation with Motiva Implants® or other aesthetic procedures as applicable.
Annual follow-up visits
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Clifton O Bingham Iii, Anna Kristina Gutierrez, Alessandra Butanis...
https://pubmed.ncbi.nlm.nih.gov/30790155/Monique E Hinchcliff, Jennifer L Beaumont, Mary A Carns...
https://pubmed.ncbi.nlm.nih.gov/25362656/Haya M Almalag, Ibrahim Almaghlouth, Rufaidah Dabbagh...
https://pubmed.ncbi.nlm.nih.gov/36862854/Kai Sun, Amanda M Eudy, Nathaniel Harris...
https://pubmed.ncbi.nlm.nih.gov/38127169/Susan J Bartlett, Anna Kristina Gutierrez, Kathleen M Andersen...
https://pubmed.ncbi.nlm.nih.gov/33166066/M M H Teuwen, I R E Knaapen, T P M Vliet Vlieland...
https://pubmed.ncbi.nlm.nih.gov/37103773/Motiva USA LLC
Lead Sponsor